期刊文献+

普罗布考联合阿托伐他汀对急性冠脉综合征患者妊娠相关血浆蛋白和高敏C反应蛋白的影响 被引量:3

The effect of probucol and atorvastatin combination on PAPP-A and hs-CRP level in patients with acute coronary syndrome
原文传递
导出
摘要 目的比较急性冠脉综合征(ACS)患者早期使用普罗布考联合阿托伐他汀与单用阿托伐他汀对妊娠相关血浆蛋白A(PAPP-A)及高敏C反应蛋白(hs-CRP)的影响。方法将90例ACS患者随机分为单独治疗组(阿托伐他汀20mg/d)和联合治疗组(普罗布考1g/d,阿托伐他汀20mg/d)。分别测量两组患者服药前和服药1个月时的血清PAPP-A、hs-CR水平。结果单独治疗组治疗前血清PAPP-A和hs-CRP水平分别为(2.09±0.69)mIU/L和(4.17±2.93)mg/L,治疗后降至(1.68±0.40)mIU/L和(2.33±2.25)mg/L。联合治疗组治疗前血清PAPP-A和hs-CRP水平分别为(2.25±0.64)mIU/L和(5.18±4.56)mg/L,治疗后降至(1.54±0.38)mIU/L和(1.60±1.11)mg/L。两组患者治疗后血清PAPP-A和hs-CRP水平较治疗前均明显降低(P<0.01),但联合治疗组降低的幅度较单独治疗组大(P<0.05)。多因素直线相关分析显示ACS患者的血清PAPP-A与hs-CRP显著相关(r=0.378,P<0.01)。结论短期使用普罗布考联合阿托伐他汀与单用阿托伐他汀均能降低ACS患者血清PAPP-A与hs-CRP水平,可能起到抑制炎症反应、稳定冠状动脉粥样斑块的作用。加用普罗布考可能发挥进一步稳定斑块的作用。 Objective To investigate the effects of probucol combined with atorvastatin and atorvastatin only on serum pregnancy-associated plasma protein-A (PAPP-A) and high-sensitivity C-reactive protein (hs-CRP) levels after 1 month. Methods Ninety patients with ACS were assigned to atorvastatin only group (20mg/d of atorvastain, n-49) or combined therapeutic group (20mg/d of atorvastain and 1.0g/d of prohucol, n=41) in a randomized, controlled study. Serum levels of PAPP-A and hs-CRP were detected before and after treatment. Results The levels of PAPP-A and hs-CRP in atorvastain only group before treatment were (2.09±0.69)mIU/L and (4.17±2.93)mg/L respectively, which decreased to (1.68± 0.40)mIU/L and (2.33±2.25)mg/L after treatment. In the combined treatment group, they were (2.25±0.64)mIU/L and (5.18± 4.56)mg/L respectively before treatment and (1.54±0.38)mIU/L and (1.60±1.11)mg/L respectively after treatment. After treated with atorvastain only and cobined therapy the levels of serum PAPP-A and hs-CRP were significantly decreased(P 〈 0.01), and those in combined therapy decreased even more markedly(P〈 0.05). Conclusions Both atorvastain alone and atorvastain combined probucol can decrease the levels of PAPP-A and hs-CRP in patients with ACS, which may reduce inflammatory reaction and stabilize plaque. Atorvastain combined with prohucol may have stronger effect on stabilizing plaque than atorvastain alone.
出处 《北京医学》 CAS 2008年第2期81-83,共3页 Beijing Medical Journal
关键词 普罗布考 阿托伐他汀 急性冠脉综合征 妊娠相关血浆蛋白A 高敏C反应蛋白 Prohucol Atorvastatin Acute coronary syndromes Pregnancy-associated plasma protein High sensitivity C-reactive protein
  • 相关文献

参考文献8

  • 1付华,刘亚林,刘宇.早期应用阿托伐他汀对急性冠脉综合征患者血清妊娠相关蛋白-A和高敏C-反应蛋白水平的影响[J].中国急救医学,2006,26(5):334-336. 被引量:4
  • 2Miedema MD, Conover CA, Harrington SC, et al. Pregnancy associated plasma protein-A levels are markedly elevated in patients with acute myocardial infarction and are proportionally decreased by atorvastatin treatment: a dual-dose, double-blind, randomized study. Poster Presentations, 2006, 5:72.
  • 3Lund J, Qin QP, Ilva T, et al. Pregnancy-associated plasma protein A: a biomarker in acute ST-elevation myocardial infarction (STEMI). Ann Med, 2006, 38: 221-228.
  • 4Alberto DR, Pedro AG, Martin GG, et al. Circulating pregnancyassociated plasma protein-A is not an early marker of acute myocardial infarction. Clin Biochem, 2005, 8:180 - 182.
  • 5Heeschen C, Dimmeler S, Hamm CW, et al, Pregnancy-associated plasma protein-A levels in patients with acute coronary syndromes: comparison with markers of systemic inflammation, platelet activation, and myocardial necrosis. J Am Coil Cardiol, 2005, 18:229 - 237.
  • 6Laterza OF, Cameron SJ, Chappell D, et al. Evaluation of pregnancy- associated plasma protein A as a prognostic indicator in acute coronary syndrome patients. Clin Chim Acta, 2004, 348: 163 - 169.
  • 7Bayes-Genis A, Conover CA, Schwartz RS, et al. The insulin-like growth factor axis:A review of atherosclerosis and restenosis. Circ Res, 2000, 86:125 - 130.
  • 8程晓静,王绿娅,刘晓惠.丙丁酚防治动脉粥样硬化的研究新进展[J].中国动脉硬化杂志,2004,12(5):611-614. 被引量:9

二级参考文献53

  • 1罗骏,刘乃丰,陈日新,张丽容.尼莫地平、维拉帕米、卡托普利及普罗布可的体外抑制脂质过氧化作用[J].南京铁道医学院学报,1996,15(2):70-73. 被引量:6
  • 2陈临溪,廖瑞芳,余麟,李立新,黄红林,朱炳阳.丙丁酚抑制氧化型低密度脂蛋白诱导的血管平滑肌细胞增殖[J].衡阳医学院学报,1997,25(2):125-128. 被引量:2
  • 3Bayes -Genis A,Conover CA,Overgaard MT,et al.Pregnancyassociated plasma protein A as a marker of acute coronary syndromes[J].New Engl J Med,2001,345 (14):1022-1029.
  • 4Braun wald E,Antman EM,Beasley JW,et al.ACC/AHA Guidelines for the management of patients with unstable angina and non-STsegment elevation myocardial infarction.A report of American College of Cardiology/American Heart Association Task Force on Practice Guidelines[J].J Am Coll Cardiol,2000,36 (3):970-1062.
  • 5Bayes-Genis A,Conover CA,Schwartz RS,et al.The insulin-like growth factor axis:a review of atherosclerosis and restenosis[J].Circ Res,2000,86(2):125-130.
  • 6Rekhter MD,Hicks GW,Brammer DW,et al.Animal model that mimics atherosclerotic plaque rupture[J].Circ Res,1998,83 (7):705 -713.
  • 7Schwartz GG,Olsson AG,Ezekowitz MD,et al.Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes:the MIRACL study:a randomized controlled trial[J].JAMA,2001,285(13):1711 -1718.
  • 8Aikawa M,Rabkin E,Sugiyama S,et al.An HMG-GOA reductase inhibitor,Cerivastatin,suppresses growth of Macrophages expressing matrix metalloproteinases and tissue factor in vivo and in vitro[J].Circulation,2001,103:276-283.
  • 9Hedblad B,Wikstrand J,Janzon L,et al,Low -dose metoprolol CR/XL and fluvastatin slow progression of carotid intima-media thickness:Main results from the Beta-Blocker Cholesterol-Lowering Asymptomatic Plaque Study (BCAPS)[J].Circulation,2001,103(13):1721 -1726.
  • 10Yamada DM,Topol EJ.Importance of microembolization and inflammation in atherosclerotic heart disease[J].Am Heart J,2000,140:S90-102.

共引文献11

同被引文献36

引证文献3

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部